Clinical Trial

Establishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic Preparedness

Name: Establishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic Preparedness — clinical trial record (NCT07305207)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The overall objective is to establish an influenza Controlled Human Infection Model (CHIM) in Canada that can be used to assess the safety and efficacy of candidate vaccines, biologics, and therapeutics targeting influenza viruses.

Trial Details

NCT Number	NCT07305207
Lead Sponsor	Dalhousie University Collaborators: Canadian Center for Vaccinology, McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions	Influenza (Healthy Volunteers)
Enrollment	32 participants
Start Date	2026-02-01
Primary Completion	2027-06-01 (estimated)
Study Completion	2028-01-31 (estimated)
Updated on ClinicalTrials.gov	2025-12-26